Skip to main content

Antonio Luis Andreu Périz

Institutions of which they are part

Predoctoral researcher
Neuromuscular and Mitochondrial Pathology
Vall Hebron Institut de Recerca

Antonio Luis Andreu Périz

Institutions of which they are part

Predoctoral researcher
Neuromuscular and Mitochondrial Pathology
Vall Hebron Institut de Recerca

Projects

Efecto de la alteración del metabolismo de nucleósidos sobre la replicación del DNA mitocondrial en MNGIE. Participación de los transportadores de nucleósidos de membrana

IP: Antonio Luis Andreu Périz
Collaborators: Ramon Martí Seves, Miriam Izquierdo Sans
Funding agency: Instituto de Salud Carlos III
Funding: 146036.97
Reference: MS04/00242
Duration: 23/02/2005 - 22/02/2011

Estudio bioquímico y molecular de los síndromes de depleción del DNA mitocondrial debidos a defectos en el metabolismo de nucleótidos

IP: Antonio Luis Andreu Périz
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding:
Reference: BF03/00551
Duration: 01/01/2004 - 31/12/2007

Estudio clínico-epidemiológico y molecular de las enfermedades de la cadena respiratoria mitocondrial en España.

IP: Antonio Luis Andreu Périz
Collaborators: Josep Gamez Carbonell
Funding agency: Instituto de Salud Carlos III
Funding: 76597
Reference: G03/011
Duration: 01/01/2003 - 31/12/2005

Análisis de la relación genotipo-fenotipo en formas geneticamente diferenciadas de Esclerosis Lateral Amiotrófica Familiar.

IP: Josep Gamez Carbonell
Collaborators: Antonio Luis Andreu Périz, Elena García Arumí, Patricia Pozo Rosich
Funding agency: Instituto de Salud Carlos III
Funding: 88665
Reference: PI020648
Duration: 06/11/2002 - 01/06/2006

Related news

The projects, selected under the 2026 Health Research and CaixaImpulse Health Innovation calls, address topics ranging from new therapies for childhood neurological disorders and Parkinson’s disease to the treatment of mitochondrial diseases and cancer.

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

Related professionals

Marta Rosales Linaeres

Marta Rosales Linaeres

Research assistant
Multidisciplinary Nursing Research Group
Read more
Sandra Liz Madrid

Sandra Liz Madrid

Research assistant
Multidisciplinary Nursing Research Group
Read more
Alejandro Fasano Illuzzi

Alejandro Fasano Illuzzi

Gestió i Administració
Technological Infrastructure Unit
Digital Transformation Directorate
Read more
Claudia Barber Caselles

Claudia Barber Caselles

Predoctoral researcher
Physiology and Pathophysiology of the Digestive Tract
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.